An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis.
about
P2860
An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
An orally administered butyrat ...... sodium-induced murine colitis.
@en
An orally administered butyrat ...... sodium-induced murine colitis.
@nl
type
label
An orally administered butyrat ...... sodium-induced murine colitis.
@en
An orally administered butyrat ...... sodium-induced murine colitis.
@nl
prefLabel
An orally administered butyrat ...... sodium-induced murine colitis.
@en
An orally administered butyrat ...... sodium-induced murine colitis.
@nl
P2093
P2860
P50
P356
P1476
An orally administered butyrat ...... sodium-induced murine colitis
@en
P2093
Anna Santoro
Antonio Calignano
Mauro Perretti
Roberto Berni Canani
Roberto Russo
P2860
P304
P356
10.1111/BPH.13637
P407
P50
P577
2016-11-03T00:00:00Z